Cargando…
HDAC inhibitors and their potential applications to glioblastoma therapy
Natural killer (NK) cells are integral components of the antitumor immune response. The downregulation of ligands for NK-cell stimulatory receptors represents a strategy whereby glioblastoma cells can evade NK-cell attacks. Histone deacetylase inhibitors can stimulate the (re)expression of these lig...
Autores principales: | Adamopoulou, Eleni, Naumann, Ulrike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805657/ https://www.ncbi.nlm.nih.gov/pubmed/24167760 http://dx.doi.org/10.4161/onci.25219 |
Ejemplares similares
-
The anticancer effects of HDAC inhibitors require the immune system
por: West, Alison C, et al.
Publicado: (2014) -
Immunological targeting of cytomegalovirus for glioblastoma therapy
por: Nair, Smita K, et al.
Publicado: (2014) -
Differentiation therapy for glioblastoma – too many obstacles?
por: Carén, Helena, et al.
Publicado: (2015) -
Convergence of EGFR glioblastoma mutations: evolution and allostery rationalizing targeted therapy
por: Orellana, Laura
Publicado: (2019) -
Immunovirotherapy for the treatment of glioblastoma
por: Cheema, Tooba A, et al.
Publicado: (2014)